About EVAHEART
About EVAHEART
Provide innovative Heart Failure and Pan-vascular solutions for global patients and healthcare professionals.
Learn More
100 %

Independently controllable industry chain

11 years

of real-world patient usage

1.5 year

Average product iteration cycle

27 Provinces

Commercial breakthrough

Core Product
<br />
<b>Notice</b>:  Undefined index: classname in <b>/www/wwwroot/evaheart.com/en/index.php</b> on line <b>122</b><br />
<br />
<b>Notice</b>:  Undefined index: classname in <b>/www/wwwroot/evaheart.com/en/index.php</b> on line <b>122</b><br />
<br />
<b>Notice</b>:  Undefined index: classname in <b>/www/wwwroot/evaheart.com/en/index.php</b> on line <b>122</b><br />

Left Ventricular Assist Device

EVAHEART EVA-Pulsar NEW EVA
The EVAHEART Left Ventricular Assist Device is China's first approved LVAD (approved in 2019). EVAHEART is specifically designed to provide circulatory mechanical support for patients with advanced refractory left ventricular heart failure. It is also the first LVAD in China to receive dual indications for both Destination Therapy and Bridge-To-Recovery support, helping heart failure patients regain a new lease on life.


EVA-Pulsar was approved for market launch in 2024. While maintaining the core advantages of the EVAHEART product series—such as high flow rate and low rotational speed—it further miniaturizes the product. EVA-Pulsar is the second LVAD product in China approved for long-term support indications, offering patients with advanced heart failure an improved implantation experience and sustained hemodynamic support.


The next-generation product NEW-EVA has now entered the validation phase, with multiple successful animal experiments completed. This product is expected to achieve multiple innovative breakthroughs in miniaturized design and pulse control technology, further enhancing implant adaptability and physiological biomimicry, bringing better treatment options to patients with end-stage heart failure.

Learn More

Customer Focus         Innovation Driven         Integrity Ownership


News & Updates
Academic Column Industry Insights

View More

Join EVAHEART — Let Your Heart Beat with the World

Recruitment Entry

Submitted successfully!

Back
Fill Again